Gujarat Terce Laboratories Ltd — Important, 04-02-2026: Company Update

Gujarat Terce Laboratories has shared its investor presentation detailing the financial results for the third quarter and nine months ended 31 December 2025. For Q3 FY26, revenue was ₹12.29 Cr (-3%), with EBITDA rising 8% to ₹1.25 Cr, reflecting improved operational efficiencies. Net Profit for the quarter stood at ₹0.74 Cr (-27%). For the nine-month period, revenue was ₹36.07 Cr (-4.75%), EBITDA ₹3.26 Cr (+6.78%), and Net Profit ₹2.10 Cr (-12.93%). Management is focused on rationalizing low-margin businesses and strengthening core brands for sustainable, margin-expanded growth.